Top Markets
Coin of the day
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.

Adagio Therapeutics, Inc.

ADGI
Rang în acțiuni #16450
Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily... Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily focused on the discovery, development, and subsequent commercialization of antibody-based therapeutics designed to combat infectious diseases across the United States. Its most advanced product candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical trials. This antibody is being evaluated for both the treatment and prevention of coronavirus disease. Adagio Therapeutics also engages in strategic collaborations. It partners with Adimab, LLC to facilitate the discovery and optimization of novel proprietary antibodies. Furthermore, the company works with the Scripps Research Institute on research initiatives aimed at identifying vaccine candidates that could prevent, diagnose, or treat influenza and beta coronaviruses. Founded in 2020, Adagio Therapeutics maintains its headquarters in Waltham, Massachusetts.
Preț acțiune
$4.64
Ultima sincronizare: 2022-09-12
Capitalizare de piață
$293.43M
Schimbare (1 zi)
0.87%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Adagio Therapeutics, Inc. (ADGI)

Categorie

Istoricul spliturilor pentru Adagio Therapeutics, Inc. (ADGI)
Acțiunea Adagio Therapeutics, Inc. (simbol: ADGI) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Sep 02, 2026.
O acțiune ADGI cumpărată înainte de Sep 02, 2026 este echivalentă astăzi cu 0 acțiuni ADGI.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH